Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Avatrombopag in Combination with Immunosuppressive Therapy in Treatment-Naïve Severe Aplastic Anemia: Results of the Diaamond-Ava-First Trial

Blood (2024) 144 (Supplement 1): 303.

https://doi.org/10.1182/blood-2024-209378

Published: 2024

Journal Articles

Cellular and Cell-Free Genomic Characterization of Patients Receiving Avatrombopag and Immunosuppressive Therapy for Treatment-Naïve Severe Aplastic Anemia

Blood (2024) 144 (Supplement 1): 1318.

https://doi.org/10.1182/blood-2024-208841

Published: 2024

Journal Articles

Initial Results from the Frailty-Stratified, Randomised Controlled Bayesian Adaptive Trial of Bortezomib Versus Lenalidomide in Transplant Ineligible Myeloma (TI-NDMM) - the FRAIL-M Study (AMaRC 19-01; ALLG MM22)

Sueh-Li Lim, John Reynolds, Lucy Pemberton, Tricia Wright, Sophie Hyesuk Lee, Peter Mollee, Anita C Shetty, Helen Weston, Nina Byard, Khoa Le, Zoe K McQuilten, Hang Quach, Andrew Spencer

Blood (2024) 144 (Supplement 1): 4755.

https://doi.org/10.1182/blood-2024-209640

Published: 2024

Journal Articles

Body Mass Index and Clinical Associations in Australasian Lymphoma Patients: A Lymphoma and Related Diseases Registry Study

Serif Sungur, Yao Yao, Cameron Wellard, Eliza Chung, Susan Morgan, Denise Lee, Geoffrey Chong, Chan Y. Cheah, Tasneem Rizvi, Eliza A. Hawkes, Zoe K McQuilten, Erica M. Wood, Nada Hamad, Tasman Armytage, Anna M. Johnston

Blood (2024) 144 (Supplement 1): 5126.

https://doi.org/10.1182/blood-2024-206277

Published: 2024

Journal Articles

Impact of Socioeconomic Status on Utilisation of ASCT and Overall Survival in Multiple Myeloma: A Report from the Australian and New Zealand (ANZ) Myeloma and Related Diseases Registry (ANZ MRDR)

Betty Gration, Cameron Wellard, Elizabeth Moore, Peter Mollee, Ian H. Kerridge, Andrew Spencer, Anita Shetty, Bart Baker, Cecily Forsyth, Jessica Heenan, Zoe K McQuilten, Erica M. Wood, Georgia McCaughan

Blood (2024) 144 (Supplement 1): 5147.

https://doi.org/10.1182/blood-2024-199451

Published: 2024

Journal Articles

A Prospective, Multinational Study of Clinical and Biological Factors Associated with Short Overall Survival in Multiple Myeloma

Andy Tang, Kihyun Kim, Fiona Chen, Zoe K McQuilten, Peter Mollee, Rajeev Rajagopal, Hang Quach, Phoebe Joy Ho, Simon J. Harrison, Andrew Spencer, Wee-Joo Chng

Blood (2023) 142 (Supplement 1): 4731.

https://doi.org/10.1182/blood-2023-178192

Published: 2023

Journal Articles

Optimizing Immunoglobulin Replacement Therapy for Patients with B-Cell Malignancies and Hypogammaglobulinemia: The Investigator-Initiated, International, Randomized Phase II/III Rational Platform Trial, and the Rationalise (STOP IgRT) Domain

Blood (2023) 142 (Supplement 1): 1295.

https://doi.org/10.1182/blood-2023-181541

Published: 2023

Journal Articles

Tranexamic Acid to Prevent Bleeding in Patients with Hematologic Malignancies and Severe Thrombocytopenia (TREATT trial). a Randomized Placebo-Controlled Trial

Blood (2023) 142 (Supplement 1): 702.

https://doi.org/10.1182/blood-2023-180720

Published: 2023

Journal Articles

Impact of 1q21 Gain and Amplification on Daratumumab-Treated Multiple Myeloma Patients: Real-World Data from the Australia-New Zealand and Asia-Pacific Myeloma and Related Diseases Registries

Kenneth J C Lim, Cameron Wellard, Elizabeth Moore, Slavisa Ninkovic, Wee-Joo Chng, Andrew Spencer, Peter Mollee, Jay Hocking, Phoebe Joy Ho, Wojt Janowski, Kihyun Kim, Karen Dun, Zoe K McQuilten, Fiona Chen, Hang Quach

Blood (2023) 142 (Supplement 1): 3325.

https://doi.org/10.1182/blood-2023-173896

Published: 2023

Journal Articles

Large Population Dataset Linkage to Understand Evolving Practice in Red Cell and Platelet Transfusion and Clinical Outcomes in Patients with Myelodysplastic Syndromes (MDS): A 15-Year Study

Allison Mo, Jake Shortt, Erica M. Wood, Zoe K McQuilten

Blood (2021) 138 (Supplement 1): 3255.

https://doi.org/10.1182/blood-2021-147132

Published: 2021

Journal Articles

How should we use convalescent plasma therapies for the management of COVID-19?

Erica M. Wood, Lise J. Estcourt, Zoe K. McQuilten

Blood (2021) 137 (12): 1573–1581.

https://doi.org/10.1182/blood.2020008903

Published: 2021

Journal Articles

T Cell Numbers Have Prognostic Value in Acute Myeloid Leukemia with Normal Cytogenetics

Victoria Y Ling, MBBS, B. MDSci, Denise Lee, MB BS, Zoe K Mcquilten, Sharon Avery, MBBS, Michael Low, MB BS, Andrew Wei, MBBS, PhD, Stephen Cody, Trung Nguyen, Catriona McLean, Professor, Stephen Ting, MB BS, FRACP, FRCPA, PhD

Blood (2014) 124 (21): 1023.

https://doi.org/10.1182/blood.V124.21.1023.1023

Published: 2014

Journal Articles

Use of Blood Components in Major Obstetric Hemorrhage: Preliminary Findings from the Australian and New Zealand Massive Transfusion Registry (ANZ-MTR)

Naomi J Aoki, Kylie Venardos, Nick Andrianopoulos, Zoe K Mcquilten, Amanda J Zatta, Claire McLintock, Helen Savoia, Erica M Wood

Blood (2014) 124 (21): 1563.

https://doi.org/10.1182/blood.V124.21.1563.1563

Published: 2014

Journal Articles

Coagulopathy Is a Strong Independent Predictor Of In-Hospital Mortality Following Massive Transfusion: Initial Results From The Australian and New Zealand Massive Transfusion Registry (ANZ-MTR)

Amanda J Zatta, BSc (Hons), PhD, Zoe K McQuilten, MBBS, Nick Andrianopoulos, MBBS, MBiostat, David J Roxby, MBBS, Naomi J Aoki, BSc, MSc, Krishna Badami, MBBS, Larry McNicol, MBBS, Ken Davis, BSc (Hons), Scott Dunkley, MBBS, Catherine Hurn, MBBS, Louise E Phillips, BSc(Hons), MPH, PhD, James P Isbister, MBBS, Peter A Cameron, MBBS, PhD, Erica M Wood, MBBS

Blood (2013) 122 (21): 2402.

https://doi.org/10.1182/blood.V122.21.2402.2402

Published: 2013

Journal Articles

Profiling Clinical Platelet and Plasma Use To Inform Blood Supply and Contingency Clanning: Puppy, The Prospective Utilization Of Platelets and Plasma Study

Mark N. Polizzotto, MBBS, BMedSc, George Grigoriadis, MBBS, PhD, BSc, Neil Waters, BSc, Mary Comande, BSc, Marija Borosak, MBBS, Zoe K. McQuilten, MBBS, Erica M. Wood, MBBS

Blood (2013) 122 (21): 3650.

https://doi.org/10.1182/blood.V122.21.3650.3650

Published: 2013

Journal Articles

Immunity In Cytogenetically Normal Acute Myeloid Leukemia (iCN-AML)

Stephen Ting, MB BS, FRACP, FRCPA, PhD, Denise Lee, MB BS, Michael Low, MB BS, Yee-May Ling, MB BS, Trung Nguyen, Zoe K McQuilten, MBBS, Stephen Cody, Catriona McLean

Blood (2013) 122 (21): 1358.

https://doi.org/10.1182/blood.V122.21.1358.1358

Published: 2013

Journal Articles

Introduction Of Universal Leucodepletion Associated With a Reduction In New Renal Failure, But Not Infection Or Mortality, In Cardiac Surgery Patients: Results From a Before and After Study

Zoe K. McQuilten, MBBS, Nick Andrianopoulos, MBBS MBiostat, Leo Van De Watering, MD PhD, Louise E. Phillips, BSc(Hons), MPH, PhD, Merrole Faye Cole-Sinclair, Christopher Reid, PhD, Peter A. Cameron, MBBS, PhD, John J. McNeil, MD, PhD, Erica M. Wood, MBBS

Blood (2013) 122 (21): 788.

https://doi.org/10.1182/blood.V122.21.788.788

Published: 2013

Journal Articles

Monosomal Karyotype Is Associated With Worse Survival Independent Of Complex Karyotype In Patients With Myelodysplastic Syndrome

Zoe K McQuilten, MBBS, Vijaya Sundararajan, MD, Erica M Wood, MBBS, David J. Curtis, M.D., Ph.D., Mark N Polizzotto, MBBS, BMedSc, Lynda J Campbell, MBBS, Meaghan Wall, MBBS (Hons), FRACP, FRCPA, PhD

Blood (2013) 122 (21): 1523.

https://doi.org/10.1182/blood.V122.21.1523.1523

Published: 2013

Journal Articles

Recombinant Activated Factor VII for Bleeding In the Setting of Malignancy or Hematopoietic Stem Cell Transplantation: The Australian and New Zealand Experience, 2000–2009,

Mark N Polizzotto, MBBS, BMedSc, Amanda J Zatta, BSc (Hons), PhD, Merrole F Cole-Sinclair, MBBS, BSc (Hons), Erica M Wood, MBBS, Zoe K McQuilten, MBBS, Scott Dunkley, MBBS FRACP FRCPA, Peter Cameron, MBBS, PhD, Louise E Phillips, BSc (Hons), MPH, PhD

Blood (2011) 118 (21): 3311.

https://doi.org/10.1182/blood.V118.21.3311.3311

Published: 2011

Journal Articles

Transfusion Association with Adverse Clinical Outcomes in Cardiac Surgery: An Analysis of a Large Patient Cohort.

Zoe K McQuilten, MBBS, Mark N Polizzotto, BMedSc, MBBS, Erica M Wood, FRACP, FRCPA, Merrole F Cole-Sinclair, MBBS, Chris Reid, Louise E Phillips, PhD, BSc, (Hons)

Blood (2009) 114 (22): 3158.

https://doi.org/10.1182/blood.V114.22.3158.3158

Published: 2009

NARROW

Efficacy and Safety of Avatrombopag in Combination with Immunosuppressive Therapy in Treatment-Naïve Severe Aplastic Anemia: Results of the Diaamond-Ava-First Trial

Cellular and Cell-Free Genomic Characterization of Patients Receiving Avatrombopag and Immunosuppressive Therapy for Treatment-Naïve Severe Aplastic Anemia

Initial Results from the Frailty-Stratified, Randomised Controlled Bayesian Adaptive Trial of Bortezomib Versus Lenalidomide in Transplant Ineligible Myeloma (TI-NDMM) - the FRAIL-M Study (AMaRC 19-01; ALLG MM22)

Body Mass Index and Clinical Associations in Australasian Lymphoma Patients: A Lymphoma and Related Diseases Registry Study

Impact of Socioeconomic Status on Utilisation of ASCT and Overall Survival in Multiple Myeloma: A Report from the Australian and New Zealand (ANZ) Myeloma and Related Diseases Registry (ANZ MRDR)

A Prospective, Multinational Study of Clinical and Biological Factors Associated with Short Overall Survival in Multiple Myeloma

Optimizing Immunoglobulin Replacement Therapy for Patients with B-Cell Malignancies and Hypogammaglobulinemia: The Investigator-Initiated, International, Randomized Phase II/III Rational Platform Trial, and the Rationalise (STOP IgRT) Domain

Tranexamic Acid to Prevent Bleeding in Patients with Hematologic Malignancies and Severe Thrombocytopenia (TREATT trial). a Randomized Placebo-Controlled Trial

Impact of 1q21 Gain and Amplification on Daratumumab-Treated Multiple Myeloma Patients: Real-World Data from the Australia-New Zealand and Asia-Pacific Myeloma and Related Diseases Registries

Large Population Dataset Linkage to Understand Evolving Practice in Red Cell and Platelet Transfusion and Clinical Outcomes in Patients with Myelodysplastic Syndromes (MDS): A 15-Year Study

How should we use convalescent plasma therapies for the management of COVID-19?

T Cell Numbers Have Prognostic Value in Acute Myeloid Leukemia with Normal Cytogenetics

Use of Blood Components in Major Obstetric Hemorrhage: Preliminary Findings from the Australian and New Zealand Massive Transfusion Registry (ANZ-MTR)

Coagulopathy Is a Strong Independent Predictor Of In-Hospital Mortality Following Massive Transfusion: Initial Results From The Australian and New Zealand Massive Transfusion Registry (ANZ-MTR)

Profiling Clinical Platelet and Plasma Use To Inform Blood Supply and Contingency Clanning: Puppy, The Prospective Utilization Of Platelets and Plasma Study

Immunity In Cytogenetically Normal Acute Myeloid Leukemia (iCN-AML)

Introduction Of Universal Leucodepletion Associated With a Reduction In New Renal Failure, But Not Infection Or Mortality, In Cardiac Surgery Patients: Results From a Before and After Study

Monosomal Karyotype Is Associated With Worse Survival Independent Of Complex Karyotype In Patients With Myelodysplastic Syndrome

Recombinant Activated Factor VII for Bleeding In the Setting of Malignancy or Hematopoietic Stem Cell Transplantation: The Australian and New Zealand Experience, 2000–2009,

Transfusion Association with Adverse Clinical Outcomes in Cardiac Surgery: An Analysis of a Large Patient Cohort.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only